| Plasma biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis ML Terpstra, J Aman, GP van Nieuw Amerongen, ABJ Groeneveld Critical care medicine 42 (3), 691-700, 2014 | 209 | 2014 |
| Effective treatment of edema and endothelial barrier dysfunction with imatinib J Aman, J van Bezu, A Damanafshan, S Huveneers, EC Eringa, SM Vogel, ... Circulation 126 (23), 2728-2738, 2012 | 184 | 2012 |
| High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote inflammation by alveolar macrophages W Hoepel, HJ Chen, CE Geyer, S Allahverdiyeva, XD Manz, SW de Taeye, ... Science translational medicine 13 (596), eabf8654, 2021 | 172 | 2021 |
| Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis CJ Rhodes, K Batai, M Bleda, M Haimel, L Southgate, M Germain, ... The lancet respiratory medicine 7 (3), 227-238, 2019 | 144 | 2019 |
| Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial J Aman, E Duijvelaar, L Botros, A Kianzad, JR Schippers, PJ Smeele, ... The Lancet Respiratory Medicine 9 (9), 957-968, 2021 | 102 | 2021 |
| Plasma protein levels are markers of pulmonary vascular permeability and degree of lung injury in critically ill patients with or at risk for acute lung injury/acute … J Aman, M van der Heijden, A van Lingen, ARJ Girbes, ... Critical care medicine 39 (1), 89-97, 2011 | 101 | 2011 |
| Targeting Abl kinases to regulate vascular leak during sepsis and acute respiratory distress syndrome AN Rizzo, J Aman, GP van Nieuw Amerongen, SM Dudek Arteriosclerosis, thrombosis, and vascular biology 35 (5), 1071-1079, 2015 | 80 | 2015 |
| Using cultured endothelial cells to study endothelial barrier dysfunction: Challenges and opportunities J Aman, EM Weijers, GP van Nieuw Amerongen, AB Malik, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 311 (2 …, 2016 | 79 | 2016 |
| Dasatinib increases endothelial permeability leading to pleural effusion C Phan, EM Jutant, L Tu, R Thuillet, A Seferian, D Montani, A Huertas, ... European Respiratory Journal 51 (1), 2018 | 63 | 2018 |
| The BCR-ABL1 inhibitors imatinib and ponatinib decrease plasma cholesterol and atherosclerosis, and nilotinib and ponatinib activate coagulation in a translational mouse model MG Pouwer, EJ Pieterman, L Verschuren, MPM Caspers, C Kluft, ... Frontiers in cardiovascular medicine 5, 55, 2018 | 59 | 2018 |
| Anti-SARS-CoV-2 IgG from severely ill COVID-19 patients promotes macrophage hyper-inflammatory responses W Hoepel, HJ Chen, S Allahverdiyeva, X Manz, J Aman, ... BioRxiv, 2020.07. 13.190140, 2020 | 57 | 2020 |
| Dissecting the effects of ischemia and reperfusion on the coronary microcirculation in a rat model of acute myocardial infarction MR Hollander, GA de Waard, LSF Konijnenberg, RME Meijer-van Putten, ... PLoS One 11 (7), e0157233, 2016 | 56 | 2016 |
| Predictors of pulmonary edema formation during fluid loading in the critically ill with presumed hypovolemia J Aman, ABJ Groeneveld, GP van Nieuw Amerongen Critical care medicine 40 (3), 793-799, 2012 | 56 | 2012 |
| ROCK2 primes the endothelium for vascular hyperpermeability responses by raising baseline junctional tension CML Beckers, N Knezevic, ET Valent, M Tauseef, R Krishnan, ... Vascular pharmacology 70, 45-54, 2015 | 38 | 2015 |
| Reversal of vascular leak with imatinib J Aman, MJL Peters, C Weenink, GP van Nieuw Amerongen, ... American journal of respiratory and critical care medicine 188 (9), 1171-1173, 2013 | 38 | 2013 |
| Successful treatment of diffuse pulmonary lymphangiomatosis with bevacizumab J Aman, E Thunnissen, MA Paul, GP van Nieuw Amerongen, ... Annals of internal medicine 156 (11), 839-840, 2012 | 38 | 2012 |
| Globular adiponectin controls insulin-mediated vasoreactivity in muscle through AMPKα2 MP de Boer, RI Meijer, EA Richter, GP van Nieuw Amerongen, P Sipkema, ... Vascular pharmacology 78, 24-35, 2016 | 37 | 2016 |
| Recent advances in pulmonary arterial hypertension MR Wilkins, J Aman, L Harbaum, A Ulrich, J Wharton, CJ Rhodes F1000Research 7, 2018 | 34 | 2018 |
| Epigenetic modification of the von Willebrand factor promoter drives platelet aggregation on the pulmonary endothelium in chronic thromboembolic pulmonary hypertension XD Manz, R Szulcek, X Pan, P Symersky, C Dickhoff, J Majolée, V Kremer, ... American journal of respiratory and critical care medicine 205 (7), 806-818, 2022 | 33 | 2022 |
| Regulation of VWF (von Willebrand factor) in inflammatory thrombosis XD Manz, HJ Bogaard, J Aman Arteriosclerosis, thrombosis, and vascular biology 42 (11), 1307-1320, 2022 | 32 | 2022 |
